相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Challenge of Genetic Variants of Uncertain Clinical Significance A Narrative Review
Wylie Burke et al.
ANNALS OF INTERNAL MEDICINE (2022)
Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States
Gregory F. Guzauskas et al.
GENETICS IN MEDICINE (2022)
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States
Scott J. Spencer et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Evaluating Costs Associated With Genetic Counseling Among Commercially Insured US Patients With Cancer From 2013 to 2019
Mya L. Roberson et al.
JAMA HEALTH FORUM (2022)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Leveraging population-based exome screening to impact clinical care: The evolution of variant assessment in the Geisinger MyCode research project
Melissa A. Kelly et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2021)
DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG)
Michael F. Murray et al.
GENETICS IN MEDICINE (2021)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Mev Dominguez-Valentin et al.
GENETICS IN MEDICINE (2020)
Population genetic screening efficiently identifies carriers of autosomal dominant diseases
J. J. Grzymski et al.
NATURE MEDICINE (2020)
Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States
Gregory F. Guzauskas et al.
JAMA NETWORK OPEN (2020)
Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis
Lei Zhang et al.
GENETICS IN MEDICINE (2019)
Cost-effectiveness of population genomic screening
David L. Veenstra et al.
GENETICS IN MEDICINE (2019)
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
Li Sun et al.
JAMA ONCOLOGY (2019)
Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature
Megan C. Roberts et al.
HEALTH AFFAIRS (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants
Kandamurugu Manickam et al.
JAMA NETWORK OPEN (2018)
Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age
Ashley Elrick et al.
JOURNAL OF GENETIC COUNSELING (2017)
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation
Tristan Snowsill et al.
HEALTH TECHNOLOGY ASSESSMENT (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer
Yonghong Li et al.
VALUE IN HEALTH (2017)
Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
Shravanthi R. Gandra et al.
CLINICAL CARDIOLOGY (2016)
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Amit V. Khera et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Genetic identification of familial hypercholesterolemia within a single US health care system
Noura S. Abul-Husn et al.
SCIENCE (2016)
A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients
Tristan Snowsill et al.
BMC CANCER (2015)
Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
Liang Lin et al.
CARDIOVASCULAR DRUGS AND THERAPY (2015)
Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
Ankur Pandya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance
Adam H. Buchanan et al.
JOURNAL OF GENETIC COUNSELING (2015)
COST OF GENOME ANALYSIS: THE SANGER SEQUENCING METHOD
L. Perrier et al.
VALUE IN HEALTH (2015)
Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative-Effectiveness Modeling Study
Benjamin Z. Galper et al.
PLOS ONE (2015)
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers
Xinglei Chai et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Prioritizing Genomic Applications for Action by Level of Evidence: A Horizon-Scanning Method
W. D. Dotson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
A Review and Meta-analysis of Colorectal Cancer Utilities
Sandjar Djalalov et al.
MEDICAL DECISION MAKING (2014)
Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer
Tuan Dinh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Don Husereau et al.
VALUE IN HEALTH (2013)
Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population
Tuan A. Dinh et al.
CANCER PREVENTION RESEARCH (2011)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Cost Estimation of Cardiovascular Disease Events in the US
Amy K. O'Sullivan et al.
PHARMACOECONOMICS (2011)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Health-state utility values in breast cancer
Tessa Peasgood et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation
D. A. Stupart et al.
FAMILIAL CANCER (2009)
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
Glenn E. Palomaki et al.
GENETICS IN MEDICINE (2009)
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment
Laura J. Havrilesky et al.
GYNECOLOGIC ONCOLOGY (2009)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Genomic medicine - Population screening in the age of genomic medicine.
MJ Khoury et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Clinical outcomes of a genomic screening program for actionable genetic conditions
Adam H. Buchanan et al.
GENETICS IN MEDICINE
分享论文
